Skip to main content

Health Care Policy and Legislation

news


News
09/25/2025
Grace Taylor, MS, MA
The Trump administration is set to launch a decade-long Medicare pilot that uses artificial intelligence (AI)-driven prior authorization to curb costs, sparking bipartisan concern over access to care and patient safety.
The Trump administration is set to launch a decade-long Medicare pilot that uses artificial intelligence (AI)-driven prior authorization to curb costs, sparking bipartisan concern over access to care and patient safety.
The Trump administration is set...
09/25/2025
First Report Managed Care
News
09/16/2025
Lisa Kuhns, PhD, MD
The No Surprises Act (NSA) has succeeded in lowering out-of-pocket spending for privately insured adults in states that previously lacked protections from surprise medical bills, though it has not significantly reduced premiums or overall...
The No Surprises Act (NSA) has succeeded in lowering out-of-pocket spending for privately insured adults in states that previously lacked protections from surprise medical bills, though it has not significantly reduced premiums or overall...
The No Surprises Act (NSA) has...
09/16/2025
First Report Managed Care
News
07/02/2025
Juliet Gallagher
The US Department of Health and Human Services (HHS) and the US Department of Justice (DOJ) announced the formation of the DOJ-HHS False Claims Act (FCA) Working Group, a joint initiative designed to strengthen enforcement efforts against...
The US Department of Health and Human Services (HHS) and the US Department of Justice (DOJ) announced the formation of the DOJ-HHS False Claims Act (FCA) Working Group, a joint initiative designed to strengthen enforcement efforts against...
The US Department of Health and...
07/02/2025
First Report Managed Care
News
11/01/2024
Juliet Gallagher
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
10/30/2024
Juliet Gallagher
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
09/13/2024
Lisa Kuhns, PhD, MD
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
The US Department of Health and...
09/13/2024
First Report Managed Care
News
08/09/2024
Lisa Kuhns, PhD, MD
The Biden-Harris Administration has announced more than $68 million in funding to improve access to HIV care for women, infants, children, and youth through the Ryan White HIV/AIDS Program.
The Biden-Harris Administration has announced more than $68 million in funding to improve access to HIV care for women, infants, children, and youth through the Ryan White HIV/AIDS Program.
The Biden-Harris Administration...
08/09/2024
First Report Managed Care
News
05/03/2024
Hannah Musick
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on laboratory-developed tests have sparked debate over access to innovative tests and patient care in the medical field, with opponents arguing that increased oversight could hinder the development of crucial new...
The FDA's new regulations on...
05/03/2024
First Report Managed Care
News
04/05/2024
Paul Nicolaus
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
03/05/2024
Hannah Musick
The Justice Department is investigating UnitedHealth’s ownership of the largest US health care insurer and its relationship with doctor groups and drug benefits amid concerns of potential antitrust violations.
The Justice Department is investigating UnitedHealth’s ownership of the largest US health care insurer and its relationship with doctor groups and drug benefits amid concerns of potential antitrust violations.
The Justice Department is...
03/05/2024
First Report Managed Care